Trademark: 97265928
Word
CELULARITY IMPACT
Status
Registered
Status Code
700
Status Date
Tuesday, July 5, 2022
Serial Number
97265928
Registration Number
6782541
Registration Date
Tuesday, July 5, 2022
Mark Type
4000
Filing Date
Monday, February 14, 2022
Published for Opposition
Tuesday, April 19, 2022

Trademark Owner History
Celularity Inc. - Original Registrant

Classifications
40 Manufacturing services of biopharmaceuticals and gene and cell therapy products, namely, genetically engineered tissues for others; manufacturing services for others in the fields of mammalian cell banks, plasmids, purified mitochondria, cell lysates; production of cells for others; custom manufacturing of cells for others; advanced cell manufacturing for others; manufacturing process consulting
42 Research, development and testing services in the fields of genomics, biotechnology and pharmaceuticals, namely, collection, testing, processing, preservation, storage and retrieval of cells and biological tissue, namely, blood, stem cells, umbilical cords, umbilical cord blood, and placental tissue; laboratory research services in the field of genomics, biotechnology and pharmaceuticals consisting of collection, testing, processing, preservation, storage and retrieval of bioengineered cells, human allograft tissue made from human umbilical cords and human placentas, human amniotic membrane and human chorionic membrane, human collagen and extracellular matrix compositions; providing a website featuring information in the field of medical research relating to banking stem cells and cord blood banking; biosourcing of clinically accessible, immune-tolerant human stem and progenitor and other postpartum placenta-derived cell populations and tissues for medical research; scientific and technological services, namely, scientific research, analysis, and testing in the field of genomics, biotechnology, and pharmaceuticals; medical research to find methods to restore the structure and function of damaged or diseased tissues and organs, including wound care, reconstructive medicine, whole organ and tissue regeneration and renewal; medical research regarding emergent cell therapies; medical research regarding allogeneic immunotherapy; providing on-line information, news and commentary in the field of medical research relating to the foregoing; research, development and testing services for others in the fields of genomics, biotechnology and pharmaceuticals

Trademark Events
Jul 5, 2022
Notice Of Registration Confirmation Emailed
Jul 5, 2022
Registered-Principal Register
Apr 19, 2022
Official Gazette Publication Confirmation E-Mailed
Apr 19, 2022
Published For Opposition
Mar 30, 2022
Notification Of Notice Of Publication E-Mailed
Mar 15, 2022
Assigned To Lie
Mar 11, 2022
Approved For Pub - Principal Register
Mar 11, 2022
Examiner's Amendment Entered
Mar 11, 2022
Notification Of Examiners Amendment E-Mailed
Mar 11, 2022
Examiners Amendment E-Mailed
Mar 11, 2022
Examiners Amendment -Written
Mar 1, 2022
Assigned To Examiner
Feb 18, 2022
New Application Office Supplied Data Entered In Tram
Feb 17, 2022
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24